These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 7544000)
21. Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba/F3 pro-B cells. Huang HM; Lin YL; Chen CH; Chang TW J Cell Biochem; 2005 Oct; 96(2):361-75. PubMed ID: 15988755 [TBL] [Abstract][Full Text] [Related]
22. TPO and IL-3 induce overlapping but distinct protein tyrosine phosphorylation in a myeloid precursor cell line. Dorsch M; Fan PD; Bogenberger J; Goff SP Biochem Biophys Res Commun; 1995 Sep; 214(2):424-31. PubMed ID: 7545904 [TBL] [Abstract][Full Text] [Related]
23. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001 [TBL] [Abstract][Full Text] [Related]
24. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells. Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031 [TBL] [Abstract][Full Text] [Related]
26. JAK3 associates with the human interleukin 4 receptor and is tyrosine phosphorylated following receptor triggering. Rolling C; Treton D; Beckmann P; Galanaud P; Richard Y Oncogene; 1995 May; 10(9):1757-61. PubMed ID: 7538655 [TBL] [Abstract][Full Text] [Related]
27. Regulation of JAK3 expression and activation in human B cells and B cell malignancies. Tortolani PJ; Lal BK; Riva A; Johnston JA; Chen YQ; Reaman GH; Beckwith M; Longo D; Ortaldo JR; Bhatia K; McGrath I; Kehrl J; Tuscano J; McVicar DW; O'Shea JJ J Immunol; 1995 Dec; 155(11):5220-6. PubMed ID: 7594533 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. Lai SY; Molden J; Liu KD; Puck JM; White MD; Goldsmith MA EMBO J; 1996 Sep; 15(17):4506-14. PubMed ID: 8887542 [TBL] [Abstract][Full Text] [Related]
29. Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: implication of CD45 as a Janus kinase phosphatase in antibody diversification. Zhou C; Saxon A; Zhang K J Immunol; 2003 Feb; 170(4):1887-93. PubMed ID: 12574355 [TBL] [Abstract][Full Text] [Related]
30. CD40-mediated regulation of interleukin-4 signaling pathways in B lymphocytes. Siepmann K; Wohlleben G; Gray D Eur J Immunol; 1996 Jul; 26(7):1544-52. PubMed ID: 8766559 [TBL] [Abstract][Full Text] [Related]
31. Signal transduction through the IL-4 and insulin receptor families. Wang LM; Keegan A; Frankel M; Paul WE; Pierce JH Stem Cells; 1995 Jul; 13(4):360-8. PubMed ID: 7549895 [TBL] [Abstract][Full Text] [Related]
33. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. Johnston JA; Wang LM; Hanson EP; Sun XJ; White MF; Oakes SA; Pierce JH; O'Shea JJ J Biol Chem; 1995 Dec; 270(48):28527-30. PubMed ID: 7499365 [TBL] [Abstract][Full Text] [Related]
34. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Russell SM; Johnston JA; Noguchi M; Kawamura M; Bacon CM; Friedmann M; Berg M; McVicar DW; Witthuhn BA; Silvennoinen O Science; 1994 Nov; 266(5187):1042-5. PubMed ID: 7973658 [TBL] [Abstract][Full Text] [Related]
35. Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. Musso T; Johnston JA; Linnekin D; Varesio L; Rowe TK; O'Shea JJ; McVicar DW J Exp Med; 1995 Apr; 181(4):1425-31. PubMed ID: 7535338 [TBL] [Abstract][Full Text] [Related]
36. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line. Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212 [TBL] [Abstract][Full Text] [Related]
37. Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11. Berger LC; Hawley TS; Lust JA; Goldman SJ; Hawley RG Biochem Biophys Res Commun; 1994 Jul; 202(1):596-605. PubMed ID: 7518681 [TBL] [Abstract][Full Text] [Related]
38. Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7. Sharfe N; Roifman CM J Immunol; 1997 Aug; 159(3):1107-14. PubMed ID: 9233603 [TBL] [Abstract][Full Text] [Related]
39. The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells. Wang HY; Zamorano J; Yoerkie JL; Paul WE; Keegan AD J Immunol; 1997 Feb; 158(3):1037-40. PubMed ID: 9013940 [TBL] [Abstract][Full Text] [Related]
40. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]